Cornercap Investment Counsel’s Medifast MED Stock Holding History

Cornercap Investment Counsel’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,593	Closed	-$331K	–	621
2023 Q2	$331K	Hold	3,593	–	–	0.06%	459
2023 Q1	$372K	Buy	3,593 +765	+27%	+$84.8K	0.07%	453
2022 Q4	$326K	Buy	2,828 +167	+6%	+$19.4K	0.06%	465
2022 Q3	$288K	Sell	2,661 -40	-1%	-$5.73K	0.05%	455
2022 Q2	$488K	Hold	2,701	–	–	0.08%	398
2022 Q1	$461K	Buy	+2,701	New	+$509K	0.05%	471
2016 Q2	–	Sell	-15,645	Closed	-$472K	–	374
2016 Q1	$472K	Hold	15,645	–	–	0.09%	266
2015 Q4	$475K	Buy	+15,645	New	+$466K	0.09%	208
2014 Q3	–	Sell	-9,850	Closed	-$300K	–	281
2014 Q2	$300K	Hold	9,850	–	–	0.05%	226
2014 Q1	$287K	Hold	9,850	–	–	0.05%	225
2013 Q4	$257K	Hold	9,850	–	–	0.05%	223
2013 Q3	$265K	Hold	9,850	–	–	0.05%	231
2013 Q2	$254K	Buy	+9,850	New	+$259K	0.05%	229

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cornercap Investment Counsel's MED Position: Q3 2023 in Review

Cornercap Investment Counsel sold out of Medifast (MED) in Q3 2023, closing a stake of 3,593 shares — an estimated $331K sold.

Cornercap Investment Counsel first reported a position in MED in Q2 2013 and held it in 13 quarters. The position peaked at $488K in Q2 2022. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

Cornercap Investment Counsel reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
Cornercap Investment Counsel sold 3,593 Medifast shares in Q3 2023, an estimated $331K.
Cornercap Investment Counsel first reported a position in Medifast in Q2 2013 and held it in 13 quarters.
Cornercap Investment Counsel's Medifast position peaked at $488K in Q2 2022.
223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Cornercap Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.